ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 64 filers reported holding ADAMAS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $557,000 | +451.5% | 105,551 | +402.3% | 0.06% | +270.6% |
Q1 2021 | $101,000 | +29.5% | 21,013 | -31.1% | 0.02% | -60.5% |
Q2 2020 | $78,000 | -25.7% | 30,484 | -16.2% | 0.04% | +65.4% |
Q1 2020 | $105,000 | -58.7% | 36,386 | -45.6% | 0.03% | -13.3% |
Q4 2019 | $254,000 | +19.8% | 66,913 | +716.0% | 0.03% | +172.7% |
Q2 2018 | $212,000 | -1.4% | 8,200 | +7.9% | 0.01% | 0.0% |
Q4 2015 | $215,000 | -60.3% | 7,600 | -76.5% | 0.01% | -59.3% |
Q3 2015 | $542,000 | +12.0% | 32,403 | +17.2% | 0.03% | +42.1% |
Q1 2015 | $484,000 | +52.7% | 27,654 | +51.7% | 0.02% | -13.6% |
Q4 2014 | $317,000 | +30.5% | 18,226 | +39.8% | 0.02% | +69.2% |
Q3 2014 | $243,000 | – | 13,040 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 1,423,578 | $8,826,000 | 6.08% |
Healthcare Value Capital, LLC | 200,000 | $1,240,000 | 2.33% |
ARMISTICE CAPITAL, LLC | 2,700,000 | $16,740,000 | 1.06% |
DELTEC ASSET MANAGEMENT LLC | 550,836 | $3,415,000 | 0.75% |
Broadfin Capital, LLC | 441,088 | $2,735,000 | 0.60% |
Kerrisdale Advisers, LLC | 229,347 | $1,422,000 | 0.51% |
Worth Venture Partners, LLC | 87,908 | $545,000 | 0.30% |
Mosaic Family Wealth, LLC | 91,314 | $566,000 | 0.24% |
EMERALD ADVISERS, LLC | 700,176 | $4,341,000 | 0.17% |
EMERALD MUTUAL FUND ADVISERS TRUST | 616,664 | $3,823,000 | 0.15% |